Santoni M.; Conti A.; Piva F.; Massari F.; Ciccarese C.; Burattini L.; Cheng L.; Lopez-Beltran A.; Scarpelli M.; Santini D.; Tortora G.; Cascinu S.; Montironi R., Role of STAT3 pathway in genitourinary tumors, «FUTURE SCIENCE OA», 2015, 1, Article number: FSO15 , pp. 1 - 9 [Scientific article]
Caffo O.; De Giorgi U.; Fratino L.; Lo Re G.; Basso U.; D'Angelo A.; Donini M.; Verderame F.; Ratta R.; Procopio G.; Campadelli E.; Massari F.; Gasparro D.; Macrini S.; Messina C.; Giordano M.; Alesini D.; Zustovich F.; Fraccon A.P.; Vicario G.; Conteduca V.; Maines F.; Galligioni E., Safety and clinical outcomes of patients treated with abiraterone acetate after docetaxel: Results of the Italian Named Patient Programme, «BJU INTERNATIONAL», 2015, 115, pp. 764 - 771 [Scientific article]
Bracarda S.; Iacovelli R.; Boni L.; Rizzo M.; Derosa L.; Rossi M.; Galli L.; Procopio G.; Sisani M.; Longo F.; Santoni M.; Morelli F.; Di Lorenzo G.; Altavilla A.; Porta C.; Camerini A.; Escudier B.; Martignetti A.; Ricotta R.; Gasparro D.; Sabbatini R.; Ceresoli G.L.; Mosca A.; Santini D.; Caserta C.; Cavanna L.; Massari F.; Sava T.; Boni C.; Verzoni E.; Carteni G.; Hamzaj A., Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: The RAINBOW analysis, «ANNALS OF ONCOLOGY», 2015, 26, pp. 2107 - 2113 [Scientific article]
Santoni M.; Conti A.; Porta C.; Procopio G.; Sternberg C.N.; Basso U.; De Giorgi U.; Bracarda S.; Rizzo M.; Ortega C.; Massari F.; Iacovelli R.; Derosa L.; Masini C.; Milella M.; Di Lorenzo G.; Atzori F.; Pagano M.; Buti S.; De Vivo R.; Mosca A.; Rossi M.; Paglino C.; Verzoni E.; Cerbone L.; Muzzonigro G.; Falconi M.; Montironi R.; Burattini L.; Santini D.; Cascinu S., Sunitinib, Pazopanib or Sorafenib for the Treatment of Patients with Late Relapsing Metastatic Renal Cell Carcinoma, «THE JOURNAL OF UROLOGY», 2015, 193, pp. 41 - 47 [Scientific article]
Ortolani S.; Ciccarese C.; Cingarlini S.; Tortora G.; Massari F., Suppression of mTOR pathway in solid tumors: Lessons learned from clinical experience in renal cell carcinoma and neuroendocrine tumors and new perspectives, «FUTURE ONCOLOGY», 2015, 11, pp. 1809 - 1828 [Scientific article]
Santoni M.; Conti A.; Partelli S.; Porta C.; Sternberg C.N.; Procopio G.; Bracarda S.; Basso U.; De Giorgi U.; Derosa L.; Rizzo M.; Ortega C.; Massari F.; Iacovelli R.; Milella M.; Di Lorenzo G.; Buti S.; Cerbone L.; Burattini L.; Montironi R.; Santini D.; Falconi M.; Cascinu S., Surgical Resection Does Not Improve Survival in Patients with Renal Metastases to the Pancreas in the Era of Tyrosine Kinase Inhibitors, «ANNALS OF SURGICAL ONCOLOGY», 2015, 22, pp. 2094 - 2100 [Scientific article]
Massari F.; Ciccarese C.; Santoni M.; Lopez-Beltran A.; Scarpelli M.; Montironi R.; Cheng L., Targeting fibroblast growth factor receptor (FGFR) pathway in renal cell carcinoma, «EXPERT REVIEW OF ANTICANCER THERAPY», 2015, 15, pp. 1367 - 1369 [Scientific article]
Massari F.; Santoni M.; Ciccarese C.; Santini D., The immunocheckpoints in modern oncology: The next 15 years, «EXPERT OPINION ON BIOLOGICAL THERAPY», 2015, 15, pp. 917 - 921 [Scientific article]
Santoni M.; Piva F.; Scarpelli M.; Cheng L.; Lopez-Beltran A.; Massari F.; Iacovelli R.; Berardi R.; Santini D.; Montironi R., The origin of prostate metastases: emerging insights, «CANCER METASTASIS REVIEWS», 2015, 34, pp. 765 - 773 [Scientific article]
Massari F.; Ciccarese C.; Santoni M.; Brunelli M.; Conti A.; Modena A.; Montironi R.; Santini D.; Cheng L.; Martignoni G.; Cascinu S.; Tortora G., The route to personalized medicine in bladder cancer: where do we stand?, «TARGETED ONCOLOGY», 2015, 10, pp. 325 - 336 [Scientific article]
Santoni M.; Conti A.; Massari F.; Arnaldi G.; Iacovelli R.; Rizzo M.; De Giorgi U.; Trementino L.; Procopio G.; Tortora G.; Cascinu S., Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: An up-to-date review and meta-analysis of clinical trials, «INTERNATIONAL JOURNAL OF CANCER», 2015, 136, pp. 1 - 10 [Scientific article]
Massari F.; Maines F.; Bria E.; Galligioni E.; Caffo O.; Tortora G., 2-weekly docetaxel: issues for clinical practice, «CANCER BIOLOGY & THERAPY», 2015, 16, pp. 17 - 18 [Scientific article]
Massari F.; Ciccarese C.; Modena A.; Maines F.; Segala D.; Luchini C.; Marcolini L.; Cavicchioli F.; Cavalleri S.; Bria E.; Brunelli M.; Martignoni G.; Artibani W.; Tortora G., Adenocarcinoma of the paraurethral glands: A case report, «HISTOLOGY AND HISTOPATHOLOGY», 2014, 29, pp. 1295 - 1303 [Scientific article]
Pilotto S.; Bonomi M.; Massari F.; Milella M.; Ciuffreda L.; Brunelli M.; Fassan M.; Chilosi M.; Scarpa A.; Tortora G.; Bria E., Anti-angiogenic drugs and biomarkers in non-small-cell lung cancer: A 'hard days night', «CURRENT PHARMACEUTICAL DESIGN», 2014, 20, pp. 3958 - 3972 [Scientific article]
Santoni M.; Bracarda S.; Nabissi M.; Massari F.; Conti A.; Bria E.; Tortora G.; Santoni G.; Cascinu S., CXC and CC chemokines as angiogenic modulators in nonhaematological tumors, «BIOMED RESEARCH INTERNATIONAL», 2014, 2014, Article number: 768758 , pp. 1 - 12 [Scientific article]
